Loading clinical trials...
Loading clinical trials...
Open-label, Multicenter, Uncontrolled, Rater-blinded, Post-market Clinical Follow-up [PMCF] Study to Confirm Performance and Safety of RADIESSE® (+) Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines, and/or Cheek Volume Loss
Conditions
Interventions
RADIESSE® (+) Lidocaine
Locations
7
Germany
Rosenpark Research, Merz Investigational Site #490099
Darmstadt, Germany
Universität Hamburg Fachbereich Chemie Institut für Biologie und Molekularbiologie , Merz Investigational Site #490095
Hamburg, Germany
Derma Science GmbH Hamburg, Merz Investigational Site #490345
Hamburg, Germany
Privatpraxis für Dermatologie und Ästhetik, Merz Investigational Site #490371
Munich, Germany
Dermatologie München-Neuhausen, Merz Investigational Site #490372
Munich, Germany
Haut-und Lasercentrum, Merz Investigational Site #0490362
Potsdam, Germany
Start Date
September 17, 2018
Primary Completion Date
May 26, 2020
Completion Date
May 26, 2020
Last Updated
December 5, 2023
Lead Sponsor
Merz North America, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions